Overview
- Oura confirmed a Series E of more than $900 million led by Fidelity Management & Research Company, with ICONIQ joining and Whale Rock and Atreides participating, valuing the company at about $11 billion.
- David Shuman becomes chair of the board, succeeding Eurie Kim, and the board expands with investor Wen Hsieh of Matter Venture Partners.
- The company reports over 5.5 million rings sold, revenue of more than $500 million in 2024 after doubling year over year, and guidance that 2025 sales are on pace to reach roughly $1 billion.
- Oura’s platform push includes the Ring 4 Ceramic and a Charging Case, Health Panels with Quest Diagnostics for in‑app lab scheduling and up to 50 biomarkers, an AI Advisor, and Dexcom glucose data integration.
- Executives highlight fastest growth among women in their early twenties and high 12‑month retention in the high 80s, as competitors like Samsung, Whoop, and Ultrahuman step up and privacy scrutiny lingers over a reported DoD deal that Oura says does not involve member data sharing.